Mirum Pharmaceuticals CEO Christopher Peetz's 2021 pay jumps 38% to $4.1M
Mirum Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 22, 2022
Mirum Pharmaceuticals reported fiscal year 2021 executive compensation information on April 22, 2022.
In 2021, four executives at Mirum Pharmaceuticals received on average a compensation package of $2.5M, a 5% increase compared to previous year.
Average pay of disclosed executives at Mirum Pharmaceuticals
Christopher Peetz, Chief Executive Officer, received $4.1M in total, which increased by 38% compared to 2020. 62% of Peetz's compensation, or $2.5M, was in option awards. Peetz also received $413K in non-equity incentive plan, $600K in salary, $560K in stock awards, as well as $12K in other compensation.
Ian Clements, Chief Financial Officer, received a compensation package of $2M, which increased by 43% compared to previous year. 55% of the compensation package, or $1.1M, was in option awards.
Edwin Tucker, Chief Medical Officer, earned $2M in 2021.
Peter Radovich, Chief Operating Officer, received $1.8M in 2021, which decreases by 32% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 22, 2022.